Sun Pharma Advanced Research Company Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 284.6 million compared to INR 219.9 million a year ago. Revenue was INR 286.4 million compared to INR 227.9 million a year ago.

Net loss was INR 823.5 million compared to INR 613.7 million a year ago. Basic loss per share from continuing operations was INR 3.03 compared to INR 2.34 a year ago.